Investing Profile
Roy Lobb
Your Intro Paths to Roy Lobb
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Roy is a member of
University of Oxford Network
96 CONNECTIONS
Find Roy Lobb on
cbCurrent Investing Position
Advent Life Sciences Venture Partner
Investment Range
$25K - $5.0M
Sweet Spot
$1M
Roy Lobb is on these Sector & Stage Rankings
Roy Lobb's Experience
director and cofounder Aleta Biotherapeutics2015 - Present
consultant & co-founder Avila Therapeutics2007 - 2012
Senior director Discovery Research Biogen1987 - 2001
Roy Lobb's Education
University of Oxford DPhil Chemistry